EUR 15.35
(3.02%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 32.46 Million EUR | 18.23% |
2022 | 27.73 Million EUR | 12.58% |
2021 | 24.63 Million EUR | 12.04% |
2020 | 21.99 Million EUR | 3.14% |
2019 | 21.32 Million EUR | -4.42% |
2018 | 22.3 Million EUR | 20.26% |
2017 | 18.55 Million EUR | 8.74% |
2016 | 17.05 Million EUR | -4.19% |
2015 | 17.8 Million EUR | 25.61% |
2014 | 14.17 Million EUR | -12.5% |
2013 | 16.19 Million EUR | 5.85% |
2012 | 15.3 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 10.01 Million EUR | 20.42% |
2024 Q1 | 8.23 Million EUR | 7.38% |
2023 Q2 | 8.69 Million EUR | 28.71% |
2023 Q1 | 6.75 Million EUR | 10.75% |
2023 FY | 32.79 Million EUR | 18.23% |
2023 Q3 | 9.93 Million EUR | 14.32% |
2023 Q4 | 7.66 Million EUR | -22.8% |
2022 Q3 | 7.7 Million EUR | -4.08% |
2022 Q2 | 8.03 Million EUR | 36.38% |
2022 Q1 | 5.89 Million EUR | 1.68% |
2022 FY | 27.73 Million EUR | 12.58% |
2022 Q4 | 6.09 Million EUR | -20.92% |
2021 FY | 24.63 Million EUR | 12.04% |
2021 Q4 | 5.79 Million EUR | -11.5% |
2021 Q3 | 6.54 Million EUR | -3.29% |
2021 Q1 | 5.52 Million EUR | 2.12% |
2021 Q2 | 6.77 Million EUR | 22.68% |
2020 FY | 21.99 Million EUR | 3.14% |
2020 Q1 | 5.09 Million EUR | 27.54% |
2020 Q2 | 5.68 Million EUR | 11.48% |
2020 Q3 | 5.8 Million EUR | 2.14% |
2020 Q4 | 5.4 Million EUR | -6.88% |
2019 Q3 | 5.53 Million EUR | -17.64% |
2019 FY | 21.32 Million EUR | -4.42% |
2019 Q2 | 6.71 Million EUR | 32.28% |
2019 Q4 | 3.99 Million EUR | -27.74% |
2019 Q1 | 5.07 Million EUR | -16.2% |
2018 FY | 22.3 Million EUR | 20.26% |
2018 Q2 | 6.28 Million EUR | 28.61% |
2018 Q4 | 6.05 Million EUR | 19.4% |
2018 Q1 | 4.88 Million EUR | 1.85% |
2018 Q3 | 5.07 Million EUR | -19.29% |
2017 Q2 | 5.74 Million EUR | 58.07% |
2017 Q3 | 4.36 Million EUR | -24.1% |
2017 Q4 | 4.79 Million EUR | 9.98% |
2017 FY | 18.55 Million EUR | 8.74% |
2017 Q1 | 3.63 Million EUR | 0.68% |
2016 Q1 | 4.75 Million EUR | -25.46% |
2016 FY | 17.05 Million EUR | -4.19% |
2016 Q3 | 3.61 Million EUR | -23.97% |
2016 Q4 | 3.61 Million EUR | 0.0% |
2016 Q2 | 4.75 Million EUR | 0.0% |
2015 FY | 17.8 Million EUR | 25.61% |
2015 Q4 | 6.37 Million EUR | 75.72% |
2015 Q3 | 3.62 Million EUR | -27.33% |
2015 Q2 | 4.99 Million EUR | 62.86% |
2015 Q1 | 3.06 Million EUR | -29.96% |
2014 Q4 | 4.37 Million EUR | 27.47% |
2014 FY | 14.17 Million EUR | -12.5% |
2014 Q3 | 3.43 Million EUR | -10.56% |
2014 Q2 | 3.83 Million EUR | 32.84% |
2014 Q1 | 2.88 Million EUR | -35.36% |
2013 Q3 | 3.71 Million EUR | -26.16% |
2013 Q4 | 4.47 Million EUR | 20.23% |
2013 FY | 16.19 Million EUR | 5.85% |
2013 Q1 | 3.33 Million EUR | -18.06% |
2013 Q2 | 5.03 Million EUR | 50.97% |
2012 FY | 15.3 Million EUR | 0.0% |
2012 Q1 | 3.14 Million EUR | 0.0% |
2012 Q3 | 3.49 Million EUR | -23.6% |
2012 Q4 | 4.07 Million EUR | 16.45% |
2012 Q2 | 4.57 Million EUR | 45.52% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Evrofarma SA | 3.03 Million EUR | -970.877% |
Flour Mills Kepenos S.A. | 9.76 Million EUR | -232.664% |
Loulis Food Ingredients S.A. | 20.52 Million EUR | -58.178% |